What Key Growth Drivers Are Shaping The In Vivo Contract Research Organization Market Forecast Toward $7.19 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The In Vivo Contract Research Organization Market Be Worth By 2029?
The market size for in vivo contract research organizations has seen robust growth in the past years. The sector is projected to expand from a value of $4.82 billion in 2024 to $5.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.5%. The growth experienced in the past can be credited to factors such as escalating drug development expenditures, a surge in chronic disease prevalence, augmentation of investment in pharmaceutical research and development, the proliferation of biotech startups, and a rising demand for innovative therapeutics.
Growth is predicted for the in vivo contract research organization market, with a potential expansion to $7.19 billion by 2029, thanks to a compound annual growth rate (CAGR) of 8.3%. Several factors may contribute to this increase during the forecast period, such as the rising demand for precision medicine and the worldwide proliferation of contract research organization services. Other influential factors include the burgeoning need for personalized therapeutics, an escalation in translational research, and an increase in the number of orphan drugs. The upcoming trends during this period will likely involve advancements in imaging techniques, the automation of data processing and reporting, incorporation of omics technologies, the use of cloud-based collaborations, and developments in biologic biosimilars.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25790&type=smp
What Market Forces Are Contributing To The Growth Of The In Vivo Contract Research Organization Market?
The increasing emphasis on personalized medicine is predicted to fuel the expansion of the in vivo contract research organization industry. Personalized medicine employs a specialized medical approach that modifies treatment and prevention strategies based on an individual’s genetic structure, lifestyle, and environment to enhance health results. The surge in personalized medicine is attributable to the growing access and affordability of genomic sequencing technologies, allowing for precise identification of genetic anomalies and facilitating personalized therapies that enhance patient outcomes and minimize trial-and-error in treatment. The intensified focus on personalized medicine is boosting demand in the in vivo CRO industry, as tailored preclinical studies using unique animal models are required to assess targeted therapies and their impact on particular genetic profiles. For example, in February 2024, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the US, reported that the FDA approved 16 new personalized treatments in 2023, a significant increase from the six approved in 2022. Personalized medicines represented over a third of all new drugs approved by the U.S. Food and Drug Administration (FDA) for the fourth year in a row. Consequently, the heightened emphasis on personalized medicine is propelling the growth of the in vivo contract research organization industry.
Which Segments Define The Structure Of The In Vivo Contract Research Organization Market?
The in vivo contract research organization market covered in this report is segmented –
1) By Type: Rodent Based, Non-Rodent Based
2) By Type Of Service: Clinical Trial Services, Preclinical Services, Post-Market Services
3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice
4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies
Subsegments:
1) By Rodent-Based: Mice Models, Rat Models, Genetically Engineered Rodents, Immunodeficient Rodents, Humanized Rodents
2) By Non-Rodent-Based: Canine Models, Non-Human Primate Models, Swine Models, Rabbit Models, Zebrafish Models
What Strategic Shifts And Innovations Are Influencing The In Vivo Contract Research Organization Market?
Firms dominating the in vivo contract research organization market are centering on creating transformative solutions such as advanced therapy incubator programs to hasten the production of future-generation treatments and aid preliminary clinical investigations. An advanced therapy incubator program is a tailored scheme to assist burgeoning biotech firms by offering resources, guidance and necessary infrastructure to fast-track the progress of innovative treatments like gene, cell, and RNA-based procedures. For example, the US-based pharmaceutical entity, Charles River Laboratories International Inc., unveiled its first-ever cohort of advanced therapy incubator program in April 2025. This ground-breaking endeavor is intended to back early-stage biotech enterprises concentrating on developing future-generation treatments. The program equips members with access to Charles River’s scientific knowledge, cutting-edge lab infrastructure and tailor-made in vivo models, expediting them to swiftly yield proof-of-concept data. This program also offers a clinical setting in the real world for validating therapeutic candidates, aiding in reducing time-to-clinic and enhancing the likelihood of regulatory validation. Acting as a bridge between academic creativity and clinical progression, the scheme significantly contributes in promoting the segment of advanced treatments.
Which Firms Are Making The Biggest Impact In The In Vivo Contract Research Organization Market?
Major companies operating in the in vivo contract research organization market are Thermo Fisher Scientific Inc., IQVIA Inc., Labcorp Drug Development Inc., ICON plc, Pharmaceutical Product Development LLC, Eurofins Scientific SE, WuXi AppTec, Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Evotec SE, GemPharmatech Co Ltd., BIOQUAL Inc., Crown Bioscience Inc., PsychoGenics Inc., Janvier Labs SAS, Taconic Bioscience Inc., Xentech SAS, Pronexus Analytical AB, Altogen Labs Inc., AniLocus Inc.
Access The Complete Report Here:
Which Region Is Forecasted To Lead The In Vivo Contract Research Organization Market In The Coming Years?
North America was the largest region in the in vivo contract research organization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo contract research organization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25790&type=smp
Browse Through More Reports Similar to the Global In Vivo Contract Research Organization Market 2025, By The Business Research Company
Contract Development Manufacturing Organizations Global Market Report 2025
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Global Market Report 2025
Topical Drugs Contract Development And Manufacturing Organization Cdmo Global Market Report 2025
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
